ATLANTA, June 11, 2013 /PRNewswire/ -- CardioMEMS, Inc., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, today announced that Chief Financial Officer, Daniel H. Bauer, has been awarded a 2013 Atlanta Business Chronicle's CFO of the Year Award in the Private Small Company category. The awards, presented in affiliation with the Association for Corporate Growth, recognize CFOs who have contributed to their company's growth and business, as well as endeavored to improve quality of service within the company and the community.
"I am honored to receive this award," said Mr. Bauer. "Working with Dr. Yadav and the incredibly talented team at CardioMEMS to bring our company's unique technology forward has been a rewarding professional challenge. It has involved the dedication of many talented professionals whose sole focus has been to improve the lives of patients."
"Dan has done a great job of financial management and communicating with our investors," said Dr. Jay Yadav. "He is also an excellent strategic thinker and has provided value well beyond the traditional CFO role."
The 2013 Atlanta CFO of the Year Awards were presented by the Atlanta Business Chronicle on Friday, May 31 at the Georgia Aquarium. Winners were chosen in seven categories: Public Company (Medium & Large Categories), Private Company (Small, Medium & Large Categories), Non Profit and Community Service.
About CardioMEMS, Inc.
CardioMEMS is a medical device company that has developed and is commercializing proprietary wireless sensing and communication technology for the human body. The company's technology platform is designed to improve the management of severe chronic cardiovascular diseases such as aneurysms, heart failure, and hypertension. CardioMEMS miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data, which are critical to the management of patients. The sensors are designed to be permanently implanted into the heart and blood vessels due to their small size, durability and lack of wires and batteries. Using radiofrequency (RF) energy, the sensors transmit real-time data to external electronic readers, which then communicate this information to the patient's physician. CardioMEMS developed this technology based on the belief that frequent, on-demand, real-time monitoring of vital information enables proactive patient management, which holds the promise of reducing hospitalizations, improving a patient's quality of life and delivering more efficient and cost effective health care. More information about CardioMEMS is located at www.cardiomems.com.
Statements made in this press release that look forward in time or that express beliefs, expectations or hopes regarding future occurrences or anticipated outcomes are forward-looking statements. A number of risks and uncertainties such as risks associated with product development and commercialization efforts, expected timing or results of any clinical trials, ultimate clinical outcome and perceived or actual advantages of the Company's products, market and physician acceptance of the products, intellectual property protection, and competitive offerings could cause actual events to adversely differ from the expectations indicated in these forward looking statements.
CardioMEMS and the CardioMEMS logo are registered trademarks of CardioMEMS, Inc. Champion is a trademark of CardioMEMS, Inc.
Caution: The Champion Heart Failure Monitoring system is an investigational device limited by federal law to investigational use.
|SOURCE CardioMEMS, Inc.|
Copyright©2012 PR Newswire.
All rights reserved